Chemomab Therapeutics | 20-F: Registration statement / Annual report / Transition report
Mar 28 18:14
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%), etc.
Mar 12 07:23
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 7 20:04
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 3 13:00
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%), etc.
Nov 16, 2023 05:35
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 9, 2023 21:00
Chemomab Therapeutics | EFFECT: Others
Nov 6, 2023 13:15
Chemomab Therapeutics | CORRESP: CORRESP
Nov 2, 2023 04:05
Chemomab Therapeutics | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
Oct 30, 2023 20:33
Chemomab Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Oct 17, 2023 04:25
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Aug 14, 2023 20:05
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 8, 2023 18:00
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Darvish Nissim
Jul 6, 2023 05:48
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Jul 4, 2023 03:49
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Quigley Jill M.
Jun 20, 2023 18:03
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Fatal Sigal
Jun 17, 2023 04:03
Chemomab Therapeutics | 8-K: Current report
Jun 17, 2023 04:01
Chemomab Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Fatal Sigal
Jun 6, 2023 04:54
Chemomab Therapeutics | 8-K: Current report
Jun 5, 2023 19:00
Chemomab Therapeutics | RW: Registration Withdrawal Request
Jun 3, 2023 04:02
No Data
No Data